Collagen IV

100% Secure

Native Human Collagen IV

Product Type
Purified Protein
Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
2150-0150 E 0.1 mg
Human collagen type IV from placenta.

Human collagen type I-III, V, VI (<5%). Non collagen proteins (<0.5%).

Product Details

Target Species
Product Form
Purified protein - liquid
Salt and alcohol precipitations, DEAE chromatography. Purity and retention of native helical structure was controlled by SDS-PAGE, ORD measurement, ability to form microfibrils and by reaction with anti-collagen type specific monoclonal antibodies.
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.09% Sodium Azide (NaN3)
SDS PAGE: >95%
Approx. Protein Concentrations
Total protein concentration 1.0mg/ml.
Molecular Weight
340 kDa

Storage Information

Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the protein. Should this product contain a precipitate we recommend microcentrifugation before use.
Shelf Life
18 months from date of despatch.

More Information

P02462 Related reagents
P08572 Related reagents
Q01955 Related reagents
P53420 Related reagents
P29400 Related reagents
Q14031 Related reagents
Entrez Gene
COL4A1 Related reagents
COL4A2 Related reagents
COL4A5 Related reagents
COL4A4 Related reagents
COL4A3 Related reagents
COL4A6 Related reagents
GO Terms
GO:0001525 angiogenesis
GO:0005201 extracellular matrix structural constituent
GO:0007411 axon guidance
GO:0048407 platelet-derived growth factor binding
GO:0005515 protein binding
GO:0005587 collagen type IV
GO:0016525 negative regulation of angiogenesis
GO:0030198 extracellular matrix organization
GO:0005605 basal lamina
GO:0032836 glomerular basement membrane development
For research purposes only

Applications of Collagen IV

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.

Product Specific References

References for Collagen IV

  1. Takahashi, S. et al. (2015) C-type lectin-like domain and fibronectin-like type II domain of phospholipase A2 receptor 1 modulate binding and migratory responses to collagen.
    FEBS Lett. 589 (7): 829-35.

Further Reading

  1. Glanville, R.W. et al. (1979) Isolation and characterization of a native placental basement-membrane collagen and its component alpha chains
    Eur. J. Biochem. 95: 383-389.
  2. Sage, H. et al . (1979) Characterization of a novel collagen chain in human placenta and its relation to AB collagen
    Biochemistry. 18: 3815-3822.
  3. Klasson, S.C. et al . (1986) The effects of tissue pretreatment and pepsin levels on the isolation of collagens from human placenta.
    Coll. Relat. Res. 6: 397-402.
  4. Bornstein, P. (1980) Structurally distinct collagen types
    Ann. Rev. Biochem. V. 49: 957-1003.